These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10432732)

  • 1. Synthesis, cytostatic activity and inhibition of ribonucleotide reductase by 5'-phosphoramidates and 5'-diphosphates, of 2'-O-allyl-arabinofuranosyl nucleosides.
    Manfredini S; Baraldi PG; Durini E; Balzarini J; De Clercq E; Karlsson A; Buzzoni V; Thelander L
    Nucleosides Nucleotides; 1999; 18(4-5):1007-8. PubMed ID: 10432732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-Phosphoramidates and 5'-diphosphates of 2'-O-allyl-beta-D-arabinofuranosyluracil, -cytosine, and -adenine: inhibition of ribonucleotide reductase.
    Manfredini S; Baraldi PG; Durini E; Vertuani S; Balzarini J; De Clercq E; Karlsson A; Buzzoni V; Thelander L
    J Med Chem; 1999 Aug; 42(17):3243-50. PubMed ID: 10464011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of phosphonoacetic acid (PPA) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors and evaluation of their enzyme inhibitory, cytostatic and antiviral activity.
    Manfredini S; Solaroli N; Angusti A; Nalin F; Durini E; Vertuani S; Pricl S; Ferrone M; Spadari S; Focher F; Verri A; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2003 Jul; 14(4):183-94. PubMed ID: 14582847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxicity of 9-(2-deoxy-2-alkyldithio-beta-D-arabinofuranosyl)purine nucleosides which are stable precursors to potential mechanistic probes of ribonucleotide reductases.
    Wnuk SF; Lewandowska E; Companioni DR; Garcia PI; Secrist JA
    Org Biomol Chem; 2004 Jan; 2(1):120-6. PubMed ID: 14737670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase.
    Farr RA; Bey P; Sunkara PS; Lippert BJ
    J Med Chem; 1989 Aug; 32(8):1879-85. PubMed ID: 2666666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acid related compounds. 74. Synthesis and biological activity of 2'(and 3')-deoxy-2'(and 3')-methylenenucleoside analogues that function as mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase and/or ribonucleotide reductase.
    Robins MJ; Samano V; Zhang W; Balzarini J; De Clercq E; Borchardt RT; Lee Y; Yuan CS
    J Med Chem; 1992 Jun; 35(12):2283-93. PubMed ID: 1613752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleotide reductase: a mechanistic portrait of substrate analogues inhibitors.
    Perez MA; Cerqueira NM; Fernandes PA; Ramos MJ
    Curr Med Chem; 2010; 17(26):2854-72. PubMed ID: 20858168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the antitumor activity and the ribonucleotide reductase inhibitory activity of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, MDL 101,731.
    Kanazawa J; Takahashi T; Akinaga S; Tamaoki T; Okabe M
    Anticancer Drugs; 1998 Aug; 9(7):653-7. PubMed ID: 9773810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azinyl and diazinyl hydrazones derived from aryl N-heteroaryl ketones: synthesis and antiproliferative activity.
    Easmon J; Heinisch G; Pürstinger G; Langer T; Osterreicher JK; Grunicke HH; Hofmann J
    J Med Chem; 1997 Dec; 40(26):4420-5. PubMed ID: 9435912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitors.
    Tamburlin-Thumin I; Crozet MP; Barrière JC; Barreau M; Riou JF; Lavelle F
    Eur J Med Chem; 2001 Jun; 36(6):561-8. PubMed ID: 11525847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd).
    Zahedi Avval F; Berndt C; Pramanik A; Holmgren A
    Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More potent linear peptide inhibitors of mammalian ribonucleotide reductase.
    Tan C; Gao Y; Kaur J; Cooperman BS
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5301-4. PubMed ID: 15454215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents.
    Cerqueira NM; Fernandes PA; Ramos MJ
    Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):11-29. PubMed ID: 18221051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
    Goddard AJ; Orr RM; Stock JA; Wilman DE
    Anticancer Drug Des; 1987 Dec; 2(3):235-45. PubMed ID: 3329526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy.
    Cerqueira NM; Pereira S; Fernandes PA; Ramos MJ
    Curr Med Chem; 2005; 12(11):1283-94. PubMed ID: 15974997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
    Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
    Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic nucleosides and nucleotides. 40. Selective inhibition of eukaryotic DNA polymerase alpha by 9-(beta-D-arabinofuranosyl)-2-(p-n-butylanilino) adenine 5'-triphosphate (BuAaraATP) and its 2'-up azido analog: synthesis and enzymatic evaluations.
    Tomikawa A; Seno M; Sato-Kiyotaki K; Ohtsuki C; Hirai T; Yamaguchi T; Kawaguchi T; Yoshida S; Saneyoshi M
    Nucleosides Nucleotides; 1998; 17(1-3):487-501. PubMed ID: 9708358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.
    Zídek Z; Potmesil P; Holý A
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):246-53. PubMed ID: 14575642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
    Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Jayaram HN; Saiko P; Graser G; Szekeres T; Grifantini M
    J Med Chem; 2008 Jul; 51(14):4260-9. PubMed ID: 18588281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselectivity of ribonucleotide reductase: a first study using stereoisomers of pyrimidine 2'-azido-2'-deoxynucleosides.
    Roy B; Verri A; Lossani A; Spadari S; Focher F; Aubertin AM; Gosselin G; Mathé C; Périgaud C
    Biochem Pharmacol; 2004 Aug; 68(4):711-8. PubMed ID: 15276078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.